*  Radiodermatitis Market Is Expected To Reach US$ 430.9 Mn By 2025 - Credence Research | MCT
The latest market report published by Credence Research, Inc. "Radiodermatitis Market - Growth, Future Prospects, Competitive Analysis, 2017 - 2025," the global radiodermatitis market was valued at US$ 295.5 Mn in 2016, and is expected to reach US$ 430.9 Mn by 2025 expanding at a CAGR of 4.18% from 2017 to 2025.. Browse the full report Radiodermatitis Market - Growth, Future Prospects, Competitive Analysis, 2017 - 2025 at http://www.credenceresearch.com/report/radiodermatitis-market. Market Insights. As per the report published in the European Oncology Nursing Socitey, 2016 as many as 95% of oncology patients opting radiation therapy will experience some degree of reaction on their skin due to radiation therapy. Currently no evidence supports of any medication present to prevent radiodermatitis. Some general ...
  http://www.mobilecomputingtoday.co.uk/6584/radiodermatitis-market-expected-reach-430-9-2025-credence-research/
*  Radiodermatitis - Pipeline Review, H2 2017
... Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Radiodermatitis - Pipeline Review, H2 2017, provides an overview of the Radiodermatitis (Toxicology) pipeline landscape.Radiodermatitis
  http://www.aarkstore.com/pharmaceuticals-healthcare/699045/radiodermatitis-pipeline-review-h2-2017
*  Radiodermatitis Market To Be Driven By Growing Number Of Cancer Patients From An Adverse Effect Of Radiation Therapy Till 2025:...
Global Radiodermatitis Market is expected to reach USD 442.1 million by 2025, according to a new report by Grand View Research, Inc. The global radiodermatitis market is expected to grow at an unprecedented rate owing to the growing prevalence of cancer patients undergoing radiation therapy. The demand for radiodermatitis treatment is also accentuated by unmet medical needs of consumers in emerging as well as developed regions. Increasing focus of government healthcare organizations for promoting awareness about available treatment products for radiodermatitisis predicted to present the market with high potential growth opportunities.. In addition, increasing R&D activities in the area of life sciences is presumed to be one of the significant factors contributing toward growth of this market. For instance, in December 2016, Mölnlycke Health Care AB entered ...
  http://www.desmoinesnewsdesk.com/story/107404/radiodermatitis-market-to-be-driven-by-growing-number-of-cancer-patients-from-an-adverse-effect-of-radiation-therapy-till-2025-grand-view-research-inc.html
*  Radiodermatitis Market To Be Driven By Growing Number Of Cancer Patients From An Adverse Effect Of Radiation Therapy Till 2025:...
Global Radiodermatitis Market is expected to reach USD 442.1 million by 2025, according to a new report by Grand View Research, Inc. The global radiodermatitis market is expected to grow at an unprecedented rate owing to the growing prevalence of cancer patients undergoing radiation therapy. The demand for radiodermatitis treatment is also accentuated by unmet medical needs of consumers in emerging as well as developed regions. Increasing focus of government healthcare organizations for promoting awareness about available treatment products for radiodermatitisis predicted to present the market with high potential growth opportunities.. In addition, increasing R&D activities in the area of life sciences is presumed to be one of the significant factors contributing toward growth of this market. For instance, in December 2016, Mölnlycke Health Care AB entered ...
  http://www.southdakotachronicle.com/radiodermatitis-market-to-be-driven-by-growing-number-of-cancer-patients-from-an-adverse-effect-of-radiation-therapy-till-2025-grand-view-research-inc.html
*  Radiodermatitis Market: - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024
Radiodermatitis, also known as radiation dermatitis, is a significant symptom caused by radiation therapy used in treating cancer as well as exposure to radiation during nuclear disasters.
  http://www.medindia.net/health-press-release/Radiodermatitis-Market-Global-Industry-Analysis-Size-Share-Growth-Trends-and-Forecast-2016-2024-306044-1.htm
*  Phototherapy 660 nm for the prevention of radiodermatitis in breast cancer patients receiving radiation therapy: study protocol...
Phototherapy 660 nm for the prevention of radiodermatitis in breast cancer patients receiving radiation therapy: study protocol for a randomized controlled trial. . Biblioteca virtual para leer y descargar libros, documentos, trabajos y tesis universitarias en PDF. Material universiario, documentación y tareas realizadas por universitarios en nuestra biblioteca. Para descargar gratis y para leer online.
  http://libros.duhnnae.com/2017/jun9/149886191661-Phototherapy-660nm-for-the-prevention-of-radiodermatitis-in-breast-cancer-patients-receiving-radiation-therapy-study-protocol-for-a-randomized-cont.php
*  "IL-1 generated subsequent to radiation-induced tissue injury contribut" by Matthew Janko, Fernando Ontiveros et al.
Radiation injury in the skin causes radiodermatitis, a condition in which the skin becomes inflamed and the epidermis can break down. This condition causes significant morbidity and if severe it can be an independent factor that contributes to radiation mortality. Radiodermatitis is seen in some settings of radiotherapy for cancer and is also of concern as a complication post-radiation exposure from accidents or weapons, such as a 'dirty bomb'. The pathogenesis of this condition is incompletely understood. Here we have developed a murine model of radiodermatitis wherein the skin is selectively injured by irradiation with high-energy electrons. Using this model we showed that the interleukin-1 (IL-1) pathway plays a significant role in the development of radiodermatitis. Mice that lack either IL-1 or the IL-1 ...
  http://escholarship.umassmed.edu/radiationoncology_pubs/22/
*  Laser InGaAlP (660Nm) to Prevent Radiodermatitis in Breast Cancer Patients Submitted to Radiation Therapy - Full Text View -...
This study will be a prospective double- blind trial. Patients with breast cancer with stages I-III undergoing to radiotherapy will be included. The participants will be allocated into an intervention group (laser therapy in 26 patients) or a control group ( in 26 patients the laser will be disabled without affecting its apparent function) , five days a week before radiotherapy . The low level laser therapy used in this trial will be Photon Lase III (DMC, approved by ANVISA for medicinal purposes). This InGaAIP laser emits a pulsed 660 nanometer beam with an average output of 80 milliwatts and the average energy density delivered to the breast will be 3 J/cm2. Skin reactions will be graded weekly by a nurse, by a radiotherapist and by an oncologist using the common toxicity criteria (CTC -developed by the National Cancer Institute ) and Acute Radiation Morbidity Scoring Criteria (developed by Radiation Therapy Oncology Group). The patients will answer the modified visual ...
  https://clinicaltrials.gov/ct2/show/NCT02003599?term=breast%2Ccancer%2Ctreatment&recr=Open&rank=12
*  Coping With Radiation Recall Dermatitis | Portsmouth Regional Hospital
Learn more about Coping With Radiation Recall Dermatitis at Portsmouth Regional Hospital Some people who had external beam radiation therapy may ...
  https://portsmouthhospital.com/hl/?/24004/
*  Involvement of Histamine Released From Mast Cells in Acute Radiation Dermatitis in Mice
A possible involvement of histamine in acute radiation dermatitis in mice was investigated. The dose of 40 Gy of gamma irradiation induced erythema and edema in C57BL/6 mice treated with vehicle. However, in C57BL/6 mice treated with chlorpheniramine and WBB6F1-W/Wv mice, erythema and edema were not observed. In all of these mice, epilation and dry desquamation were induced, but bepotastine significantly reduced the extent of these areas. These results suggest that gamma irradiation-induced erythema and edema were caused by histamine released from mast cells via histamine H1 receptor, and epilation was induced by other inflammatory mediators ...
  https://www.jstage.jst.go.jp/article/jphs/104/2/104_2_187/_article
*  Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for...
RATIONALE: Steroid therapy, such as mometasone furoate, may prevent radiation dermatitis caused by radiation therapy. It is not yet known whether mometasone furoate is more effective than a placebo in preventing radiation dermatitis.. PURPOSE: This randomized phase III trial is studying mometasone furoate to see how well it works compared to a placebo in preventing radiation dermatitis in patients undergoing radiation therapy to the breast or chest wall for invasive breast cancer or ductal carcinoma in situ. ...
  https://clinicaltrials.gov/ct/show/NCT00438659?order=15
*  Low-level laser therapy ameliorates radiation dermatitis
Low-level laser therapy (LLLT) ameliorated radiation dermatitis in a pilot trial conducted in 79 patients with breast cancer, known as the DERMIS trial. LLLT is a noninvasive modality that involves the application of light to injuries and lesions and promotes wound healing, the investigators explain, and the pilot study showed that it had beneficial effects on radiation dermatitis, they add.. MedScape. ...
  http://www.actionradiotherapy.org/low-level-laser-therapy-ameliorates-radiation-dermatitis/
*  Amelioration of Radiation-induced Skin Injury by HIV-TAT-Mediated Protein Transduction of RP-1 from Rana pleurade [Abstract]
Abstract. Radiation-induced reactive oxygen species (ROS) can damage DNA and most other biological macromolecules in skin and radiation-induced skin injury is a serious concern for radiation therapy. Skin possesses an extremely efficient antioxidant system, which is conferred by two systems: antioxidant enzymes and small molecules that can scavenge ROS by donating electrons. Amphibian skin is a multifunctional organ, which protects against dangers of various oxidative stresses. Recently, a small peptide called RP-1 was isolated from the skin secretions of Rana pleurade, which shows strong antioxidant activity. However, this RP-1 peptide is limited because its inability to across the cell membrane. Protein transduction domains (PTDs) have demonstrated high efficiency for facilitating the internalization of both homologous and heterogeneous proteins into cells. This study aims to elucidate the protective effects of a HIV-TAT (TAT) PTD-coupled RP-1 fusion ...
  http://www.medsci.org/v11p0044
*  KeraStat Skin Therapy in Treating Radiation Dermatitis in Patients With Newly Diagnosed Stage 0-IIIA Breast Cancer - Full Text...
PRIMARY OBJECTIVES:. I. To obtain a preliminary estimate the incidence of early adverse skin reaction (EASR) during radiation therapy (RT) and up to two months post RT after the application of the cosmetic cream KeraStat Skin Therapy during RT in breast cancer patients in a pilot study.. SECONDARY OBJECTIVES:. I. To associate personal characteristics (e.g., race/ethnicity, age, hormone therapy, smoking status, comorbidities, breast size) and treatment characteristics (e.g., RT dose) to incidence of EASR at any time point.. OUTLINE:. Patients apply KeraStat Skin Therapy topically twice daily (BID) during radiation therapy.. After completion of study treatment, patients are followed up at 1 and 2 months. ...
  https://clinicaltrials.gov/ct2/show/NCT02168179?term=breast+AND+neoplasms&lup_s=05%2F22%2F2014&lup_d=30
*  In vivo surface dose measurement using GafChromic film dosimetry in breast cancer radiotherapy: comparison of 7-field IMRT,...
The unique feature of our study is that patients were treated with a treatment plan using two radiation techniques (3D-CRT and TB-IMRT or TB-IMRT and 7 F-IMRT), and that the resulting superficial doses of the compared pairs of radiotherapy techniques were evaluated in the same patient. The advantage of this study design is that possible factors influencing the superficial dose (for example factors related to the patient set-up) are minimized and therefore observed differences are most probably related to the different radiation techniques.. Our in vivo GafChromic film dosimetry data show that 7 F-IMRT significantly reduces the surface dose compared to TB-IMRT or 3D-CRT in the adjuvant radiotherapy of breast cancer. A corresponding observation was obtained for the calculated skin dose derived from DVHs.. Our results are in excellent agreement with a film-based phantom study using an anthropomorphic female thorax phantom and GafChromic films for the dose measurements[19]. In ...
  http://ro-journal.biomedcentral.com.preview-live.oscarjournals.springer.com/articles/10.1186/1748-717X-9-156
*  Breast Cancer Radiotherapy Raises Risk Of Heart Disease Slightly - Redorbit
April Flowers for redOrbit.com - Your Universe Online. Doctors have known for quite a while that radiation treatment for breast cancer increases a woman's risk of heart disease, but the extent of that additional risk was unknown. A new study, published in a recent online issue of The New England Journal of Medicine (NEJM), further explains those risks.. The New York Times reports that a new study led by the University of Oxford's Clinical Trial Service Unit (CTSU) offers a way to estimate the risk. The study finds the risk is modest for most women and is outweighed by the benefit from the treatment. For breast cancer, radiation can halve the recurrence rate and lower the death rate by about one-sixth.. For example, a 50-year-old woman with no prior cardiovascular risks has a 1.9 percent chance of dying of heart disease before her 80th birthday. That risk increases to between 2.4 and 3.4 percent with radiation therapy for breast cancer, depending on how much ...
  http://www.redorbit.com/news/health/1112804163/heart-disease-linked-breast-cancer-radiotherapy-031513/
*  All-in-One Nursing Care Planning Resource: Medical-Surgical, by Pamela L. Swearingen - Manuel Monroy Book Archive
Expose the ulcer to air, if possible. A dark, moist, warm environment may promote bacterial growth and delay healing. Be alert to signs of infection at the ulcerated site. Local warmth, swelling, tenderness, erythema, and purulent drainage may be present at the site of ulceration and should be reported to the health care provider for treatment. Radiation Recall Reaction: Explain why radiation recall can occur and its signs and symptoms. Radiation recall can occur when chemotherapy is given after treatment with radiation therapy. Interferon, IL-2) or radiation recall reaction and should be treated aggressively. It may be accompanied by a rash and eventual desquamation. Teach strategies for treating this condition. - Apply creams and water-based lotions several times a day, avoiding perfumed products. - Avoid hot bathing water and use only mild soaps. - Manage pruritus with antipruritic medications such as diphenhydramine or ...
  http://manuel-monroy.com/books/all-in-one-nursing-care-planning-resource-medical-surgical-pediatric
*  Will you have Radiation skin injury with Eligard - from FDA reports - eHealthMe
NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.. WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.. DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.. You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).. If you ...
  https://www.ehealthme.com/ds/eligard/radiation-skin-injury/
*  Severe skin reaction secondary to concomitant radiotherapy plus cetuximab | Radiation Oncology | Full Text
The skin rash by EGFRI is thought to be the direct consequence of the EGFR blockade in basal epidermal keratinocytes as well as the outer root sheath of hair follicles, leading to a local growth arrest and consecutive inflammation. Its occurrence may be a pharmacodynamic marker of the drug action and has been proposed as surrogate parameter of tumour response [9, 10].. EGFRI are increasingly used in parallel to, or, at least, in short sequence to radiotherapy. For example, combined treatment with cetuximab and radiotherapy has been shown to improve locoregional control in patients with squamous cell carcinoma of the head and neck in a phase 3 trial [1]. Whereas the administration of cetuximab led to a significant amount of EGFRI-induced skin rashes in the combined treatment group (8.2% vs. 0.5%, p , 0.001), no statistically significant exacerbation of radiation dermatitis was reported (23 vs. 18% grade 3-5 reactions, p = 0.27).. In recent times, however, ...
  http://ro-journal.biomedcentral.com.preview-live.oscarjournals.springer.com/articles/10.1186/1748-717X-3-5
*  Desquamation of newborn | definition of desquamation of newborn by Medical dictionary
Looking for online definition of desquamation of newborn in the Medical Dictionary? desquamation of newborn explanation free. What is desquamation of newborn? Meaning of desquamation of newborn medical term. What does desquamation of newborn mean?
  http://medical-dictionary.thefreedictionary.com/desquamation+of+newborn
*  Acute skin eruptions | Murtagh's General Practice, 6e | Murtagh Collection | McGraw-Hill Medical
The sudden appearance of a rash, which is a common presentation in children (see CHAPTER 93), usually provokes patients and doctors alike to consider an infectious aetiology, commonly of viral origin. However, an important cause to consider is a reaction to a drug. ...
  http://murtagh.mhmedical.com/content.aspx?bookid=1522§ionid=116045049
*  Acute skin eruptions | Murtagh's General Practice, 6e | Murtagh Collection | McGraw-Hill Medical
The sudden appearance of a rash, which is a common presentation in children (see CHAPTER 93), usually provokes patients and doctors alike to consider an infectious aetiology, commonly of viral origin. However, an important cause to consider is a reaction to a drug. ...
  http://murtagh.mhmedical.com/content.aspx?bookid=1522§ionid=126141711
*  Swasthya vardhak breast caps Breast size, Natural Breast Success - November 26, 2017
Breast size join our community. We offer 220 products in our store. Our store specialize in supplying special featured herbal medecines, developed to improve your life and makes better your health. Swasthya vardhak breast caps.
  http://natural-breast-success.com/breast-size/swasthya-vardhak-breast-caps.html
*  Breast size is an indicator of successful breastfeeding Natural Breast Success - November 24, 2017
join our community. We offer 220 products in our store. Our store specialize in supplying special featured herbal medecines, developed to improve your life and makes better your health. Breast size is an indicator of successful breastfeedingbreastfeeding | Breastfeeding | Infants.
  http://natural-breast-success.com/breast-size-is-an-indicator-of-successful-breastfeeding.html